BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12066203)

  • 1. Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
    Nakamura H; Horita S; Senmaru N; Miyasaka Y; Gohda T; Inoue Y; Fujita M; Meguro T; Morita T; Nagashima K
    Oncol Rep; 2002; 9(4):751-5. PubMed ID: 12066203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
    Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K
    J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic significance of the molecular markers in human gastrointestinal cancer].
    Itoh F; Imai K
    Rinsho Byori; 2003 Feb; 51(2):158-67. PubMed ID: 12690634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
    Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
    J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
    Yamamoto H; Adachi Y; Itoh F; Iku S; Matsuno K; Kusano M; Arimura Y; Endo T; Hinoda Y; Hosokawa M; Imai K
    Cancer Res; 1999 Jul; 59(14):3313-6. PubMed ID: 10416584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
    Yamamoto H; Horiuchi S; Adachi Y; Taniguchi H; Nosho K; Min Y; Imai K
    Carcinogenesis; 2004 Mar; 25(3):325-32. PubMed ID: 14604892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
    Yamamoto H; Itoh F; Iku S; Hosokawa M; Imai K
    Clin Cancer Res; 2001 Apr; 7(4):896-900. PubMed ID: 11309339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.
    Salmela MT; Karjalainen-Lindsberg ML; Puolakkainen P; Saarialho-Kere U
    Br J Cancer; 2001 Aug; 85(3):383-92. PubMed ID: 11487270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
    Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
    Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.
    Juuti A; Lundin J; Nordling S; Louhimo J; Haglund C
    Oncology; 2006; 71(1-2):61-8. PubMed ID: 17377415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
    Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
    Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
    de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
    J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
    Masaki T; Matsuoka H; Sugiyama M; Abe N; Goto A; Sakamoto A; Atomi Y
    Br J Cancer; 2001 May; 84(10):1317-21. PubMed ID: 11355941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
    Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K
    J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
    Newell KJ; Matrisian LM; Driman DK
    Mol Carcinog; 2002 Jun; 34(2):59-63. PubMed ID: 12112311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer.
    Kitoh T; Yanai H; Saitoh Y; Nakamura Y; Matsubara Y; Kitoh H; Yoshida T; Okita K
    J Gastroenterol; 2004; 39(5):434-40. PubMed ID: 15175941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.